Venture Capital
Syncona Limited
Syncona Limited backs early-stage and high-growth companies, typically pre-profit, from London, United Kingdom. It states a focus on healthcare & life sciences.
Stated investment criteria
What Syncona Limited says it buys
Read from Syncona Limited’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Syncona Limited to consider any particular business, and nothing on this page is represented as being for sale.
Portfolio
Disclosed holdings
Companies Syncona Limited lists on its own website. No investment years are published.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| 14MG | — | — | — |
| Anaveon | — | — | — |
| Autolus Therapeutics | — | — | — |
| Azeria Therapeutics | — | — | — |
| Beacon Therapeutics | — | — | — |
| Blue Earth | — | — | — |
| Clade Therapeutics | — | — | — |
| Forcefield Therapeutics | — | — | — |
| Gyroscope Therapeutics | — | — | — |
| Kesmalea Therapeutics | — | — | — |
| Mosaic Therapeutics | — | — | — |
| Neogene Therapeutics | — | — | — |
| Nightstar | — | — | — |
| OMass Therapeutics | — | — | — |
| Purespring Therapeutics | — | — | — |
| Quell Therapeutics | — | — | — |
| Re-Aim Therapeutics | — | — | — |
| Resolution Therapeutics | — | — | — |
| Slingshot Therapeutics | — | — | — |
| Spur Therapeutics | — | — | — |
| Yellowstone Biosciences | — | — | — |
| iOnctura | — | — | — |
| threethirty.studio | — | — | — |
Compiled from Syncona Limited’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Syncona Limited?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other venture capital investors active in healthcare & life sciences.